CAR-T Cells Produce 100% ORR in Advanced Multiple Myeloma – Clinical Oncology News
|
CAR–T Cells Produce 100% ORR in Advanced Multiple Myeloma
Clinical Oncology News Chicago—In an early clinical experience, a novel autologous chimeric antigen receptor T (CAR–T) cell therapy resulted in a remarkable 100% objective response rate (ORR) in multiple myeloma. In patients with a follow-up of at least four months, all … |
